Assuntos
Biometria/métodos , Teste para COVID-19 , COVID-19/epidemiologia , Serviços de Saúde/provisão & distribuição , Oftalmologia/tendências , SARS-CoV-2 , Infecções Assintomáticas , COVID-19/transmissão , Portador Sadio/diagnóstico , Humanos , Transmissão de Doença Infecciosa do Paciente para o Profissional/prevenção & controle , Prevalência , ProbabilidadeRESUMO
PURPOSE: To describe the immediate consequences of SARS-CoV-2 and the COVID-19 pandemic on the ocular surface and eye-care professionals, and to discuss the need for a mandatory switch from currently performed tele-screening to true teleconsultation for remote ocular surface assessment. MAIN FINDINGS: Ophthalmologists have been largely impacted by the COVID-19 sanitary crisis, due to both the ocular manifestations of SARS-CoV-2 and to the high contagiousness of the virus. The proximity of ophthalmologists to their patients have pushed eye-care providers to readapt their practices and develop alternatives to face-to-face consultations. However, teleconsultation has some major limitations and drawbacks, especially for ocular surface assessment that relies on high-quality graphic data for adequate diagnosis. Tele-screening, on the other hand, emphasizes on the importance of history-taking and listening to the patient in order to adequately prioritize appointments based on the presumed degree of emergency. CONCLUSION: Despite all the enthusiasm, tele-screening as currently performed with the available tools is still not capable of completely replacing a standard ophthalmic examination for the assessment of ocular surface diseases. While waiting for new emerging technologies and future implementation of imaging modalities and artificial intelligence, decision making algorithms can help eye-practitioners remotely screen their patients to assess the optimal time for follow-up appointments.
Assuntos
COVID-19/epidemiologia , Controle de Doenças Transmissíveis/métodos , Doenças da Túnica Conjuntiva/diagnóstico , Doenças da Córnea/diagnóstico , Atenção à Saúde/tendências , Síndromes do Olho Seco/diagnóstico , SARS-CoV-2 , Pessoal de Saúde , Humanos , Oftalmologia/tendências , Exame Físico/métodos , Telemedicina/métodosRESUMO
Recently, telemedicine has become remarkably important, due to increased deployment and development of digital technologies. National and international guidelines should consider its inclusion in their updates. During the COVID-19 pandemic, mandatory social distancing and the lack of effective treatments has made telemedicine the safest interactive system between patients, both infected and uninfected, and clinicians. A few potential evidence-based scenarios for the application of telemedicine have been hypothesized. In particular, its use in diabetes and complication monitoring has been remarkably increasing, due to the high risk of poor prognosis. New evidence and technological improvements in telemedicine application in diabetic retinopathy (DR) have demonstrated efficacy and usefulness in screening. Moreover, despite an initial increase for devices and training costs, teleophthalmology demonstrated a good cost-to-efficacy ratio; however, no national screening program has yet focused on DR prevention and diagnosis. Lack of data during the COVID-19 pandemic strongly limits the possibility of tracing the real management of the disease, which is only conceivable from past evidence in normal conditions. The pandemic further stressed the importance of remote monitoring. However, the deployment of device and digital application used to increase screening of individuals and monitor progression of retinal disease needs to be easily accessible to general practitioners.
Assuntos
Infecções por Coronavirus/epidemiologia , Retinopatia Diabética/diagnóstico , Retinopatia Diabética/terapia , Pandemias , Pneumonia Viral/epidemiologia , Telemedicina , Betacoronavirus/fisiologia , COVID-19 , Análise Custo-Benefício , Retinopatia Diabética/epidemiologia , Humanos , Programas de Rastreamento/economia , Programas de Rastreamento/métodos , Programas de Rastreamento/organização & administração , Programas de Rastreamento/tendências , Oftalmologia/economia , Oftalmologia/métodos , Oftalmologia/organização & administração , Oftalmologia/tendências , SARS-CoV-2 , Telemedicina/economia , Telemedicina/organização & administração , Telemedicina/normas , Telemedicina/tendênciasRESUMO
PURPOSE OF REVIEW: Diabetic retinopathy is the most common specific complication of diabetes mellitus. Traditional care for patients with diabetes and diabetic retinopathy is fragmented, uncoordinated and delivered in a piecemeal nature, often in the most expensive and high-resource tertiary settings. Transformative new models incorporating digital technology are needed to address these gaps in clinical care. RECENT FINDINGS: Artificial intelligence and telehealth may improve access, financial sustainability and coverage of diabetic retinopathy screening programs. They enable risk stratifying patients based on individual risk of vision-threatening diabetic retinopathy including diabetic macular edema (DME), and predicting which patients with DME best respond to antivascular endothelial growth factor therapy. SUMMARY: Progress in artificial intelligence and tele-ophthalmology for diabetic retinopathy screening, including artificial intelligence applications in 'real-world settings' and cost-effectiveness studies are summarized. Furthermore, the initial research on the use of artificial intelligence models for diabetic retinopathy risk stratification and management of DME are outlined along with potential future directions. Finally, the need for artificial intelligence adoption within ophthalmology in response to coronavirus disease 2019 is discussed. Digital health solutions such as artificial intelligence and telehealth can facilitate the integration of community, primary and specialist eye care services, optimize the flow of patients within healthcare networks, and improve the efficiency of diabetic retinopathy management.
Assuntos
Inteligência Artificial , Retinopatia Diabética/diagnóstico , Análise Custo-Benefício , Acessibilidade aos Serviços de Saúde , Humanos , Oftalmologia/economia , Oftalmologia/tendências , Telemedicina/economia , Telemedicina/métodosAssuntos
Invenções/tendências , Investimentos em Saúde/tendências , Obstetrícia/tendências , Patentes como Assunto/estatística & dados numéricos , Cardiologia/tendências , Dermatologia/tendências , Gastroenterologia/tendências , Humanos , Oftalmologia/tendências , Ortopedia/tendências , Estudos RetrospectivosAssuntos
Betacoronavirus , Infecções por Coronavirus/epidemiologia , Atenção à Saúde/organização & administração , Atenção à Saúde/tendências , Oftalmopatias/diagnóstico , Doenças do Sistema Nervoso/diagnóstico , Pneumonia Viral/epidemiologia , Saúde Pública/tendências , Pesquisa Biomédica/organização & administração , COVID-19 , Educação Continuada/organização & administração , Oftalmopatias/terapia , Humanos , Doenças do Sistema Nervoso/terapia , Neurologia/tendências , Oftalmologia/tendências , Pandemias , Política Pública , SARS-CoV-2 , Telemedicina/organização & administraçãoRESUMO
Comparison of a customized disposable kit with a conventional stainless steel instrument was performed for an intravitreal injection. A total of 2700 eyes of 2250 patients were enrolled in two groups. Comfort level of the patients was assessed using a 'Pain Scale' and any post intravitreal injection complications were examined clinically by a slit lamp biomicroscopy. Surgeon's ease was assessed by a questionnaire. In group A, no pain was recorded in 1231(82.06%) eyes, mild pain was d escribed in 184(12.27%), moderate pain was documented in 78 (5.2%) while, severe pain was noticed in 7(0.47%). In group B, no pain was seen in 1014(84.5%), mild pain was present in 123(10.25%), moderate pain was perceived in 58 (4.83%) while, severe pain was recorded in 5 (0.42%). With respect to surgeon's ease, 6 out of the 7 surgeons found the kit to be more convenient and cost effective as compared to the conventional instruments. Disposable intravitreal kit is beneficial for both the patients as well as the surgeons.
Assuntos
Injeções Intravítreas , Dor Processual , Instrumentos Cirúrgicos , Análise Custo-Benefício , Equipamentos Descartáveis , Desenho de Equipamento/métodos , Feminino , Humanos , Injeções Intravítreas/efeitos adversos , Injeções Intravítreas/instrumentação , Injeções Intravítreas/métodos , Masculino , Teste de Materiais/métodos , Pessoa de Meia-Idade , Oftalmologia/métodos , Oftalmologia/tendências , Medição da Dor/métodos , Medição da Dor/estatística & dados numéricos , Dor Processual/diagnóstico , Dor Processual/etiologia , Dor Processual/prevenção & controle , Paquistão , Instrumentos Cirúrgicos/efeitos adversos , Instrumentos Cirúrgicos/normasRESUMO
PURPOSE: To identify temporal and geographic trends in private equity (PE)-backed acquisitions of ophthalmology and optometry practices in the United States. DESIGN: A cross-sectional study using private equity acquisition and investment data from January 1, 2012, through October 20, 2019. PARTICIPANTS: A total of 228 PE acquisitions of ophthalmology and optometry practices in the United States between 2012 and 2019. METHODS: Acquisition and financial investment data were compiled from 6 financial databases, 4 industry news outlets, and publicly available press releases from PE firms or platform companies. MAIN OUTCOME MEASURES: Yearly trends in ophthalmology and optometry acquisitions, including number of total acquisitions, clinical locations, and providers of acquired practices as well as subsequent sales, median holding period, geographic footprint, and financing status of each platform company. RESULTS: A total of 228 practices associated with 1466 clinical locations and 2146 ophthalmologists or optometrists were acquired by 29 PE-backed platform companies. Of these acquisitions, 127, 9, and 92 were comprehensive or multispecialty, retina, and optometry practices, respectively. Acquisitions increased rapidly between 2012 and 2019: 42 practices were acquired between 2012 and 2016 compared to 186 from 2017 through 2019. Financing rounds of platform companies paralleled temporal acquisition trends. Three platform companies, comprising 60% of platforms formed before 2016, were subsequently sold or recapitalized to new PE investors by the end of this study period with a median holding period of 3.5 years. In terms of geographic distribution, acquisitions occurred in 40 states with most PE firms developing multistate platform companies. New York and California were the 2 states with the greatest number of PE acquisitions with 22 and 19, respectively. CONCLUSIONS: Private equity-backed acquisitions of ophthalmology and optometry practices have increased rapidly since 2012, with some platform companies having already been sold or recapitalized to new investors. Additionally, private equity-backed platform companies have developed both regionally focused and multistate models of add-on acquisitions. Future research should assess the impact of PE investment on patient, provider, and practice metrics, including health outcomes, expenditures, procedural volume, and staff employment.
Assuntos
Administração Financeira/tendências , Oftalmologia/tendências , Optometria/tendências , Setor Privado/tendências , Prática Profissional/tendências , Estudos Transversais , Bases de Dados Factuais , Administração Financeira/economia , Geografia , Humanos , Oftalmologistas/estatística & dados numéricos , Oftalmologia/economia , Optometristas/estatística & dados numéricos , Optometria/economia , Setor Privado/economia , Estados UnidosRESUMO
The fate of pediatric ophthalmology may be in jeopardy. For the past 20 years, there has been declining interest in the field compared to other subspecialties in ophthalmology, as fellowship positions and jobs remain unfilled. Of those fellows who do match in pediatric ophthalmology and strabismus, many are international medical graduates who often return to their native countries to practice, further diminishing the supply of pediatric ophthalmologists in the United States. In previous surveys, resident graduates have expressed disinterest in the field, reluctance to work with children, inadequate reimbursements, and insufficient interactions with faculty as reasons not to pursue this subspecialty. Millions of people throughout the United States do not have access to pediatric ophthalmologists, highlighting the issue of unequal distribution. As more pediatric ophthalmologists retire, there is concern that there will not be enough providers to meet the demands of this subspecialty. Although many of these factors deterring residents from entering this field have been resolved, the major issue of financial reimbursements has not been adequately addressed. [J Pediatr Ophthalmol Strabismus. 2020;57(1):9-11.].
Assuntos
Necessidades e Demandas de Serviços de Saúde/tendências , Mão de Obra em Saúde/tendências , Oftalmologia/tendências , Pediatria/tendências , Escolha da Profissão , Necessidades e Demandas de Serviços de Saúde/estatística & dados numéricos , Mão de Obra em Saúde/estatística & dados numéricos , Humanos , Oftalmologia/economia , Pediatria/economia , Especialização/tendênciasRESUMO
PURPOSE OF REVIEW: We discuss opportunities to address key barriers to widespread implementation of teleophthalmology programs for diabetic eye screening in the United States (U.S.). RECENT FINDINGS: Teleophthalmology is an evidence-based form of diabetic eye screening. This technology has been proven to substantially increase diabetic eye screening rates and decrease blindness. However, teleophthalmology implementation remains limited among U.S. health systems. Major barriers include financial concerns as well as limited utilization by providers, clinical staff, and patients. Possible interventions include increasingly affordable camera technology, demonstration of financially sustainable billing models, and engaging key stakeholders. Significant opportunities exist to overcome barriers to scale up and promote widespread implementation of teleophthalmology in the USA. Further development of methods to sustain effective increases in diabetic eye screening rates using this technology is needed. In addition, the demonstration of cost-effectiveness in a variety of billing models should be investigated to facilitate widespread implementation of teleophthalmology in U.S. health systems.
Assuntos
Retinopatia Diabética/diagnóstico , Programas de Rastreamento/métodos , Telemedicina/métodos , Análise Custo-Benefício , Acessibilidade aos Serviços de Saúde/economia , Acessibilidade aos Serviços de Saúde/tendências , Humanos , Programas de Rastreamento/economia , Programas de Rastreamento/tendências , Oftalmologia/economia , Oftalmologia/métodos , Oftalmologia/tendências , Telemedicina/economia , Telemedicina/tendências , Estados UnidosAssuntos
Inteligência Artificial , Oftalmologia/tendências , Robótica , Big Data , Engenharia Biomédica/tendências , Biônica , Simulação por Computador , Previsões , Engenharia Genética , Humanos , Invenções , Oftalmologia/instrumentação , Oftalmologia/métodos , Oftalmologia/organização & administraçãoAssuntos
Técnicas de Diagnóstico Oftalmológico/tendências , Oftalmologistas , Oftalmologia/tendências , Padrões de Prática Médica , Competência Profissional/estatística & dados numéricos , Tecnologia/tendências , Humanos , Oftalmologistas/educação , Oftalmologia/educação , Oftalmologia/normas , Inovação Organizacional , Autonomia ProfissionalAssuntos
Tecnologia Biomédica/organização & administração , Atenção à Saúde/métodos , Acessibilidade aos Serviços de Saúde/organização & administração , Invenções/tendências , Oftalmologia/tendências , Smartphone , Telemedicina/métodos , Humanos , Estados Unidos , United States Food and Drug AdministrationRESUMO
In contradiction to fundamental laws of supply and demand, 2 decades of payment policies have led to some medical specialties experiencing declines in both manpower and reimbursement. This paradox has resulted in increasingly long wait times to see some specialists, some specialties becoming less attractive to potential trainees, and a dearth of new trainees entering these fields. Evolving models of health care delivery hold the promise of increasing patient access to most providers and may diminish costs and improve outcomes for most patients/conditions. However, patients who need care in understaffed fields may, in the future, be unable to quickly access a specialist with the requisite expertise. Impeding the sickest and most complex patients from seeing physicians with appropriate expertise may lead to increased costs and deleterious outcomes-consequences contrary to the goals of health care reform. To ensure appropriate access for these patients requires 2 conditions: 1. Compensation models that do not discourage trainees from pursuing nonprocedural specialties, and 2. A care delivery model that expediently identifies and routes these patients to the appropriate specialist.
Assuntos
Atenção à Saúde/organização & administração , Reforma dos Serviços de Saúde , Neurologia/tendências , Oftalmologia/tendências , HumanosRESUMO
PURPOSE: To analyze trends in US pediatric ophthalmology and strabismus (PO&S) Match over the last 16 years. METHODS: We reviewed the PO&S Match outcomes from 2000 to 2015, evaluating the number of participating programs, positions offered, and match rate, comparing it with other subspecialties, and analyzing results of US graduates versus international medical graduates (IMGs). A survey of PO&S program directors explored exposure to PO&S, policies on acceptance of IMGs, fellowship gross salary, job opportunities, and fellow placement after training. RESULTS: The PO&S matching rate varied yearly but was consistently lower compared to other subspecialties. The supply of fellowship positions was always higher than the demand, with as annual average of 32% unmatched positions, ranging from a low of 12% in the year 2010 to a high of 52% unmatched positions in 2004. In 2013 to 2015, 31% (from 24% to 38%) of PO&S matched fellows were IMGs, which is significantly more compared to all other ophthalmic subspecialties combined during the same time period (mean, 15%; from 15% to 16%; P < 0.001) and a significant increase from the 3 years before (mean, 20%; from 12% to 26%; P = 0.041). Our survey revealed that academic and clinical exposure of residents to PO&S usually begins during the first year of residency (PGY2). Residents spend on average 16 weeks of their training in PO&S, often with more than one faculty member. CONCLUSIONS: Interest in PO&S remains lower than other ophthalmology subspecialties despite an apparent national need for trained pediatric ophthalmologists.